S&P 500   2,671.01 (+0.28%)
DOW   22,759.48 (+0.35%)
QQQ   197.42 (+0.48%)
AAPL   262.09 (-0.14%)
FB   169.10 (+2.14%)
MSFT   165.34 (+0.04%)
GOOGL   1,193.25 (+0.85%)
AMZN   2,016.26 (+0.93%)
CGC   14.49 (+1.05%)
NVDA   260.45 (-2.96%)
MU   46.61 (+0.52%)
GE   7.04 (-2.76%)
TSLA   545.87 (+5.74%)
AMD   47.94 (+0.88%)
T   30.32 (+2.99%)
ACB   0.80 (+0.00%)
F   4.67 (+3.09%)
NFLX   374.34 (-1.48%)
BAC   22.25 (+4.02%)
GILD   74.91 (-3.63%)
DIS   101.34 (+1.77%)
S&P 500   2,671.01 (+0.28%)
DOW   22,759.48 (+0.35%)
QQQ   197.42 (+0.48%)
AAPL   262.09 (-0.14%)
FB   169.10 (+2.14%)
MSFT   165.34 (+0.04%)
GOOGL   1,193.25 (+0.85%)
AMZN   2,016.26 (+0.93%)
CGC   14.49 (+1.05%)
NVDA   260.45 (-2.96%)
MU   46.61 (+0.52%)
GE   7.04 (-2.76%)
TSLA   545.87 (+5.74%)
AMD   47.94 (+0.88%)
T   30.32 (+2.99%)
ACB   0.80 (+0.00%)
F   4.67 (+3.09%)
NFLX   374.34 (-1.48%)
BAC   22.25 (+4.02%)
GILD   74.91 (-3.63%)
DIS   101.34 (+1.77%)
S&P 500   2,671.01 (+0.28%)
DOW   22,759.48 (+0.35%)
QQQ   197.42 (+0.48%)
AAPL   262.09 (-0.14%)
FB   169.10 (+2.14%)
MSFT   165.34 (+0.04%)
GOOGL   1,193.25 (+0.85%)
AMZN   2,016.26 (+0.93%)
CGC   14.49 (+1.05%)
NVDA   260.45 (-2.96%)
MU   46.61 (+0.52%)
GE   7.04 (-2.76%)
TSLA   545.87 (+5.74%)
AMD   47.94 (+0.88%)
T   30.32 (+2.99%)
ACB   0.80 (+0.00%)
F   4.67 (+3.09%)
NFLX   374.34 (-1.48%)
BAC   22.25 (+4.02%)
GILD   74.91 (-3.63%)
DIS   101.34 (+1.77%)
S&P 500   2,671.01 (+0.28%)
DOW   22,759.48 (+0.35%)
QQQ   197.42 (+0.48%)
AAPL   262.09 (-0.14%)
FB   169.10 (+2.14%)
MSFT   165.34 (+0.04%)
GOOGL   1,193.25 (+0.85%)
AMZN   2,016.26 (+0.93%)
CGC   14.49 (+1.05%)
NVDA   260.45 (-2.96%)
MU   46.61 (+0.52%)
GE   7.04 (-2.76%)
TSLA   545.87 (+5.74%)
AMD   47.94 (+0.88%)
T   30.32 (+2.99%)
ACB   0.80 (+0.00%)
F   4.67 (+3.09%)
NFLX   374.34 (-1.48%)
BAC   22.25 (+4.02%)
GILD   74.91 (-3.63%)
DIS   101.34 (+1.77%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TricidaZymeworksAimmune TherapeuticsHeron TherapeuticsIronwood Pharmaceuticals
SymbolNASDAQ:TCDANYSE:ZYMENASDAQ:AIMTNASDAQ:HRTXNASDAQ:IRWD
Price Information
Current Price$24.71$35.69$14.98$13.09$9.82
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$49.33$48.09$43.45$44.00$14.00
% Upside from Price Target99.65% upside34.75% upside190.08% upside236.13% upside42.57% upside
Trade Information
Market Cap$1.25 billion$1.53 billion$837.26 million$1.18 billion$1.65 billion
Beta1.361.470.921.481.75
Average Volume298,051491,6192,016,8601,802,8152,089,953
Sales & Book Value
Annual RevenueN/A$29.54 millionN/A$145.97 million$428.41 million
Price / SalesN/A55.00N/A8.103.63
CashflowN/AN/AN/AN/A$0.58 per share
Price / CashN/AN/AN/AN/A17.07
Book Value$5.32 per share$6.24 per share$1.66 per share$4.48 per share($0.59) per share
Price / BookN/A5.72N/A2.92-16.64
Profitability
Net Income$-176,810,000.00$-145,440,000.00$-248,500,000.00$-204,750,000.00$21.50 million
EPS($3.72)($3.83)($3.97)($2.50)$0.55
Trailing P/E RatioN/AN/AN/AN/A75.54
Forward P/E RatioN/AN/AN/AN/A13.83
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-492.27%N/A-140.27%5.02%
Return on Equity (ROE)-65.31%-54.92%-138.44%-61.74%-46.52%
Return on Assets (ROA)-50.82%-40.94%-90.72%-46.71%23.09%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.25%N/A0.50%0.03%N/A
Current Ratio7.87%3.78%3.14%4.95%7.50%
Quick Ratio7.87%3.78%3.14%4.70%7.48%
Ownership Information
Institutional Ownership Percentage80.22%55.53%74.69%N/AN/A
Insider Ownership Percentage66.70%4.20%13.75%12.56%5.90%
Miscellaneous
Employees76180228198515
Shares Outstanding49.85 million45.52 million62.67 million90.37 million158.21 million
Next Earnings Date5/13/2020 (Estimated)5/7/2020 (Estimated)5/13/2020 (Estimated)5/14/2020 (Estimated)5/7/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel